Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.32 +0.01 (+3.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Long-Term Debt Repayments (2021 - 2023)

Updated

Senti Biosciences Holdings' Long-Term Debt Repayments was $23,000 in Q4 2023, unchanged from the prior quarter.

Analysis

Senti Biosciences Holdings (SNTI) Long-Term Debt Repayments (2021 - 2023) Analysis & Trends

For FY2023, Long-Term Debt Repayments at Senti Biosciences Holdings came in at $108,000.

  • In earlier years, Long-Term Debt Repayments was $250,000 in FY2021.
  • Quarterly Long-Term Debt Repayments has moved between $23,000 (Q3 2023) and $250,000 (Q3 2021) over five years.
  • Per Business Quant data, SNTI's Long-Term Debt Repayments in the three quarters before Q4 2023 was $23,000 (Q3 2023), $27,000 (Q2 2023) and $35,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Senti Biosciences Holdings 9.65 Mn 9.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 23,000.00
Sep 30, 2023 23,000.00
Jun 30, 2023 27,000.00
Mar 31, 2023 35,000.00
Jun 30, 2021 250,000.00
API Access

Senti Biosciences Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SNTI&period=max&api_key=YOUR_API_KEY